Mode
Text Size
Log in / Sign up
Phase 3 Completed N=40 Supportive Care

Evaluation of a Binaural Spatialization Method for Hearing Aids

Source: ClinicalTrials.gov NCT02693704 ↗
Enrolled (actual)
40
Serious AEs
0.0%
Results posted
Oct 2016
Primary outcomePrimary: Speech Intelligibility — 63; 60; 59; 48 Percentage of understood word
◆ Published Evidence
Emerging
4citations · ~1 / year
Effects of Binaural Spatialization in Wireless Microphone Systems for Hearing Aids on Normal-Hearing and Hearing-Impaired Listeners.
Trends in hearing · 2018 · Open access · Likely link

Summary

This study investigates the possible benefits of using binaural spatialization techniques in digital wireless microphone systems for hearing aids. Speech intelligibility tests, speaker localization tests and preference tests are performed. The results of a diotic (current rendering) and a binaural (suggested rendering) rendering are compared.

Linked Publications

  • Effects of Binaural Spatialization in Wireless Microphone Systems for Hearing Aids on Normal-Hearing and Hearing-Impaired Listeners.
    Trends in hearing · 2018 · 4 citations · Open access · Likely link

Outcome Measures

OutcomeResultp-value
PRIMARY
Speech Intelligibility
63; 60; 59; 48; 68; 67
PRIMARY
Speaker's Localization
0.13; 0.45; 0.5; 2.02; 0.3; 0.33
PRIMARY
Listener's Subjective Preference
60; 50; 45; 30; 35; 35

Eligibility Criteria

Inclusion Criteria

  • French-native speakers and adults.
  • Normal otoscopy.
  • No conductive pathology.
  • Normal hearing, or moderate to severe, sloping or flat, symmetrical hearing loss.
  • User of bilateral Phonak hearing aids, for more than 6 months (hearing-impaired only).

Exclusion Criteria

  • History of tinnitus or hyperacusis.
  • Visual impairment, after correction with glasses or not.
  • History of chronic or terminal illness or psychiatric disturbance,.
  • History of epilepsy or other reactions associated with the proximity to a video screen.
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT02693704) and the linked publication. Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.

Back to search